Results 181 to 190 of about 1,171,277 (292)

Fulminant drug-induced immune thrombocytopenia in polycystic kidney disease with cyst infection. [PDF]

CEN Case Rep
Iwamura N, Matsukuma Y, Iwamura K, Zhang Y, Yamada S, Nakamura K, Sakoda T, Kanaji S, Nakano T, Ago T.   +9 more
europepmc   +1 more source

Sustained Response After a Six-Week Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia. [PDF]

Mediterr J Hematol Infect Dis
Güllü Koca T, Yanık AM.
europepmc   +1 more source

Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

British Journal of Haematology, EarlyView.
Minimal residual disease (MRD)–guided ibrutinib and venetoclax (IVen) achieved durable remissions and high undetectable MRD (uMRD) rates in patients with high‐risk chronic lymphocytic leukaemia (CLL). Compared with historical ibrutinib monotherapy, IVen was associated with improved progression‐free and overall survival despite presence of complex ...
Maria Kislova, Elena Dmitrieva, Elena Naumova, Margarita Pochtar, Svetlana Lugovskaya, Yury Kobzev, Alla Loban, Maria Gladysheva, Tatiana Obukhova, Bella Biderman, Andrey Sudarikov, Egor Volchkov, Maria Ivanova, Vadim Ptushkin, Andrea Visentin, Eugene Nikitin   +15 more
wiley   +1 more source

Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia. [PDF]

Front Immunol
Huang N, Liu Z, Li R, Lei H, Liu X.
europepmc   +1 more source

Increased anergic B cells and decreased antibody‐secreting cells during romiplostim treatment in patients with immune thrombocytopenia

British Journal of Haematology, EarlyView.
Summary Patients with immune thrombocytopenia (ITP) exhibit substantial heterogeneity in treatment responses. Approximately 30%–50% of patients maintain remission after discontinuation of thrombopoietin receptor agonists (TPO‐RA), suggesting immunomodulatory effects beyond enhanced thrombopoiesis.
Vivianne S. Nelson, Rebeca Gutiérrez‐Cózar, Rebecca Cornelis, S. Marieke van Ham, Anja ten Brinke, Rick Kapur   +5 more
wiley   +1 more source

Drug-Induced Immune Thrombocytopenia Secondary to Trimethoprim-Sulfamethoxazole. [PDF]

Case Rep Infect Dis
Cimperman C, Whitesel E, Ray A, Murphy NN, Atyia S, Kourouni I, Hileman C.   +6 more
europepmc   +1 more source

BrECADD in three days: Implementation of a condensed intensive first‐line regimen in Hodgkin lymphoma

British Journal of Haematology, EarlyView.
BrECADD can be delivered over 3 days instead of four, reducing intravenous treatment days by 25% without compromising dose intensity. Among 30 patients with advanced‐stage Hodgkin lymphoma, no unexpected toxicity was observed; there were no early discontinuations, and 1‐year progression‐free and overall survival were both 100%.
Christian Peter Jaworek, Maja Supprian, Paul Jan Bröckelmann, Hishan Tharmaseelan, Justin Ferdinandus, Dennis A. Eichenauer, Anne Sophie Robertz, Janina Jablonski, Vincent Combüchen, Jan‐Oliver Staak, Karin Töpelt, Jan‐Michel Heger, Jon Rischewski, Jannik Stemler, Wolfram Klapper, Peter Borchmann, Bastian von Tresckow   +16 more
wiley   +1 more source

Factors associated with response to rituximab in patients with immune thrombocytopenia. [PDF]

Hemasphere
Tsykunova G, Kristiansen EB, Tvedt THA, Frederiksen H, Christiansen CF, Linder M, Bahmanyar S, Ghanima W.   +7 more
europepmc   +1 more source

Autoimmune neutropenia in children: Test cells versus beads and a role for pro‐LL‐37 and absolute neutrophil count

British Journal of Haematology, EarlyView.
A comparison between bead‐based and cell‐based assays for autoantibody detection in childhood neutropenia revealed substantial discordance between platforms. Bead‐based methods should be complemented with cell‐based methods for optimal diagnostic sensitivity. Incorporating pro‐LL‐37 and ANC measurements into the clinical workup of childhood neutropenia
Paul Ratcliffe, Alexandra Haara Löfstedt, Mikael Sundin, Petter Höglund   +3 more
wiley   +1 more source

Corticosteroids plus statins in patients with primary immune thrombocytopenia and hyperlipidemia: A multicenter retrospective cohort study. [PDF]

Ther Adv Hematol
Hou X, Zhao Y, Chen J, Sun L, Dong Q, Yuan C, Lv J, Liu S, Gao N, Hou M, Peng J, Yan Z, Liu X.   +12 more
europepmc   +1 more source